357 related articles for article (PubMed ID: 12411099)
1. Glomerular chemokine expression and the effect of steroid and cyclophosphamide pulse therapy in human crescentic glomerulonephritis.
Chen S; Liu Z; Chen H; Zhou H; Wang J; Li L
Chin Med J (Engl); 2002 Sep; 115(9):1301-7. PubMed ID: 12411099
[TBL] [Abstract][Full Text] [Related]
2. Glomerular expression of C-C chemokines in different types of human crescentic glomerulonephritis.
Liu ZH; Chen SF; Zhou H; Chen HP; Li LS
Nephrol Dial Transplant; 2003 Aug; 18(8):1526-34. PubMed ID: 12897090
[TBL] [Abstract][Full Text] [Related]
3. Effects of pulse methylprednisolone on macrophage chemotactic protein-1 and macrophage inflammatory protein-1alpha in rheumatoid synovium.
Wong PK; Cuello C; Bertouch JV; Roberts-Thomson PJ; Ahern MJ; Smith MD; Youssef PP
J Rheumatol; 2001 Dec; 28(12):2634-6. PubMed ID: 11764208
[TBL] [Abstract][Full Text] [Related]
4. MIP-1alpha and MCP-1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis.
Wada T; Furuichi K; Segawa-Takaeda C; Shimizu M; Sakai N; Takeda SI; Takasawa K; Kida H; Kobayashi KI; Mukaida N; Ohmoto Y; Matsushima K; Yokoyama H
Kidney Int; 1999 Sep; 56(3):995-1003. PubMed ID: 10469367
[TBL] [Abstract][Full Text] [Related]
5. Effects of methylprednisolone and cyclophosphamide pulse therapy on renal infiltrating cells in patients with crescentic glomerulonephritis.
Tang Z; Zhou H; Yao X; Hu W; Leishi L
Chin Med J (Engl); 1997 Mar; 110(3):206-9. PubMed ID: 9594342
[TBL] [Abstract][Full Text] [Related]
6. Gene expression of CC chemokines in experimental crescentic glomerulonephritis (CGN).
Natori Y; Sekiguchi M; Ou Z; Natori Y
Clin Exp Immunol; 1997 Jul; 109(1):143-8. PubMed ID: 9218837
[TBL] [Abstract][Full Text] [Related]
7. Glomerular expression of monocyte chemoattractant protein-1 is predictive of poor renal prognosis in pediatric lupus nephritis.
Marks SD; Williams SJ; Tullus K; Sebire NJ
Nephrol Dial Transplant; 2008 Nov; 23(11):3521-6. PubMed ID: 18495743
[TBL] [Abstract][Full Text] [Related]
8. CC chemokine concentrations increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia.
Baier RJ; Majid A; Parupia H; Loggins J; Kruger TE
Pediatr Pulmonol; 2004 Feb; 37(2):137-48. PubMed ID: 14730659
[TBL] [Abstract][Full Text] [Related]
9. CC chemokines and chemokine receptors in IgA nephropathy (IgAN) and in non-IgA mesangial proliferative glomerulonephritis (MesProGN). the immunohistochemical comparative study.
Wagrowska-Danilewicz M; Danilewicz M; Stasikowska O
Pol J Pathol; 2005; 56(3):121-6. PubMed ID: 16334979
[TBL] [Abstract][Full Text] [Related]
10. In situ analysis of C-C chemokine mRNA in human glomerulonephritis.
Cockwell P; Howie AJ; Adu D; Savage CO
Kidney Int; 1998 Sep; 54(3):827-36. PubMed ID: 9734607
[TBL] [Abstract][Full Text] [Related]
11. Effects of bacterial cell wall components (PAMPs) on the expression of monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and the chemokine receptor CCR2 by purified human blood monocytes.
Møller AS; Øvstebø R; Westvik AB; Joø GB; Haug KB; Kierulf P
J Endotoxin Res; 2003; 9(6):349-60. PubMed ID: 14733721
[TBL] [Abstract][Full Text] [Related]
12. Effects of intraarticular glucocorticoids on macrophage infiltration and mediators of joint damage in osteoarthritis synovial membranes: findings in a double-blind, placebo-controlled study.
Young L; Katrib A; Cuello C; Vollmer-Conna U; Bertouch JV; Roberts-Thomson PJ; Ahern MJ; Smith MD; Youssef PP
Arthritis Rheum; 2001 Feb; 44(2):343-50. PubMed ID: 11229465
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of chemokines in acute myocardial infarction.
Kobusiak-Prokopowicz M; Orzeszko J; Mazur G; Mysiak A; Orda A; Mazurek W
Kardiol Pol; 2005 Apr; 62(4):301-14; discussion 315-6. PubMed ID: 15928736
[TBL] [Abstract][Full Text] [Related]
14. Intravenous "pulse" cyclophosphamide therapy of crescentic glomerulonephritis.
Kunis CL; Kiss B; Williams G; D'Agati V; Appel GB
Clin Nephrol; 1992 Jan; 37(1):1-7. PubMed ID: 1541058
[TBL] [Abstract][Full Text] [Related]
15. Beta-chemokine function in experimental lung ischemia-reperfusion injury.
Krishnadasan B; Farivar AS; Naidu BV; Woolley SM; Byrne K; Fraga CH; Mulligan MS
Ann Thorac Surg; 2004 Mar; 77(3):1056-62. PubMed ID: 14992926
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of chemokines and chemokine receptors in inflammatory periapical diseases.
Silva TA; Garlet GP; Lara VS; Martins W; Silva JS; Cunha FQ
Oral Microbiol Immunol; 2005 Oct; 20(5):310-6. PubMed ID: 16101967
[TBL] [Abstract][Full Text] [Related]
17. Correlative insights into immunoexpression of monocyte chemoattractant protein-1, transforming growth factor beta-1 and CD68+ cells in lupus nephritis.
Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
Pol J Pathol; 2005; 56(3):115-20. PubMed ID: 16334978
[TBL] [Abstract][Full Text] [Related]
18. Monocyte chemoattractant protein-1 expression in renal tissue is associated with monocyte recruitment and tubulo-interstitial lesions in patients with lupus nephritis.
Dai C; Liu Z; Zhou H; Li L
Chin Med J (Engl); 2001 Aug; 114(8):864-8. PubMed ID: 11780369
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of the chemokine receptor, CCR5.
Mueller A; Mahmoud NG; Goedecke MC; McKeating JA; Strange PG
Br J Pharmacol; 2002 Feb; 135(4):1033-43. PubMed ID: 11861332
[TBL] [Abstract][Full Text] [Related]
20. Expression of the chemokine monocyte chemoattractant protein-1 and its receptor chemokine receptor 2 in human crescentic glomerulonephritis.
Segerer S; Cui Y; Hudkins KL; Goodpaster T; Eitner F; Mack M; Schlöndorff D; Alpers CE
J Am Soc Nephrol; 2000 Dec; 11(12):2231-2242. PubMed ID: 11095646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
